Follow the TETRALOGIC PHARMACEUTICALS CORP share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €990. The latest transaction was filed on 10 February 2016 (Cession). Among the most active insiders: Clarus Lifesciences II, L.P.. Every trade is openly available.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
11 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.